Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

9 Nov 2015 07:00

RNS Number : 9286E
Kingspan Group PLC
09 November 2015
 

Kingspan Group plc

Interim Management Statement

 

 

9 November 2015

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues an Interim Management Statement, with trading information for the period to 30 September 2015.

Sales in the nine month period to 30 September were €2.0bn, up 44% on the comparable period in the prior year (+34% pre currency). A strong sales performance was recorded in the third quarter boosted by the contribution from acquisitions with sales up 54% (+46% pre currency). Underlying sales, pre currency and acquisitions, were up 3% both in the year to date and third quarter.

Insulated Panel sales in the first nine months increased by 54% (+46% pre currency), and by 73% (+65% pre currency) in the third quarter. Underlying sales were 4% ahead year to date and by 5% in the third quarter. The UK continues to perform solidly, albeit with some moderation since September. Mainland Europe recorded a steady sales performance overall with reasonable activity in most key markets. North American sales have grown strongly in the year to date with the US outpacing Canada, which has been more variable. Activity in Australasia has stabilised more recently although year to date sales are behind the prior year.

Insulation Board sales in the first nine months were up 39% (+29% pre currency) and by 38% in quarter three (+29% pre currency). Underlying sales growth, pre currency and acquisitions, was 4% year to date and 1% in the third quarter. In particular, the pace of sales growth in certain segments of the UK market has moderated since late summer and we have seen a decline in sales in Australia in a tighter market. Mainland European sales have been relatively stable overall, and growing in the Benelux, whilst North American sales continue to progress positively.

Environmental sales in the first nine months and in the third quarter were up 8% (-1% pre currency). The trend of improvement in profitability evident in the first half has continued in the period since.

Access Floors sales in the first nine months increased by 17% (+1% pre currency). Sales in the third quarter increased by 9% (-3% pre currency). The US office market has been softer in more recent months, albeit relatively stable at current levels.

Net debt at the end of September 2015 was €413.8m, which is €306.1m higher than at the same point in 2014 due to acquisition activity year on year. Net debt at year end is forecast to be in the region of €380m.

 

2015 to date has been a significant period for Kingspan with a further step up in the breadth of the Group providing strong channels for future growth in market penetration. Integration of both the Joris Ide and VicWest businesses remains fully on track. Group underlying sales have shown c. 3% growth for much of the year with individual markets trending differently. Considering our current orderbook, this revenue pattern is likely to continue over the coming months. Profitability has benefitted from strong operating leverage, and has been further complemented by unusually favourable exchange rates and a positive input cost environment.

 

Assuming current exchange rates prevail, we expect to deliver a full year trading profit of approximately €250m (+68% versus 2014), cognisant that much of the seasonally variable fourth quarter remains. We are also mindful that the first quarter of 2016 will include the full weakness of the winter season for the businesses acquired this year, and which were not consolidated in the Group's results in the early part of 2015.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBRSGBGUL
Date   Source Headline
18th Aug 20237:05 amRNSDelisting from the London Stock Exchange
18th Aug 20237:00 amRNSHalf-year Report
20th Jul 202311:37 amRNSResult of EGM
20th Jul 20239:56 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSAcquisition
11th Jul 20237:00 amRNSTrading Update
3rd Jul 20232:40 pmRNSBlock listing Interim Review
3rd Jul 20232:34 pmRNSTotal Voting Rights
30th Jun 20234:54 pmRNSHolding(s) in Company
26th Jun 20232:00 pmRNSCircular and Notice of EGM
23rd Jun 20234:08 pmRNSHolding(s) in Company
14th Jun 20234:56 pmRNSHolding(s) in Company
14th Jun 20234:54 pmRNSHolding(s) in Company
1st Jun 20235:25 pmRNSTotal Voting Rights
2nd May 20235:09 pmRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirectorate Change
28th Apr 20234:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Statement
3rd Apr 20234:40 pmRNSTotal Voting Rights
30th Mar 20239:00 amRNSDirector/PDMR Shareholding
21st Mar 20235:24 pmRNSDirector/PDMR Shareholding
20th Mar 20235:29 pmRNSHolding(s) in Company
20th Mar 20235:28 pmRNSHolding(s) in Company
16th Mar 20234:29 pmRNSHolding(s) in Company
16th Mar 20232:05 pmRNSNotice of AGM
1st Mar 20234:28 pmRNSTotal Voting Rights
1st Mar 20233:33 pmRNSHolding(s) in Company
1st Mar 202312:39 pmRNSDirector/PDMR Shareholding
28th Feb 20231:11 pmRNSDirector/PDMR Shareholding
24th Feb 20231:09 pmRNSHolding(s) in Company
23rd Feb 20234:57 pmRNSAnnual Financial Report
23rd Feb 20239:00 amRNSDirector/PDMR Shareholding
21st Feb 20235:34 pmRNSDirector/PDMR Shareholding
21st Feb 20235:28 pmRNSDirector/PDMR Shareholding
17th Feb 20237:30 amRNSDirectorate Change
17th Feb 20237:00 amRNSFinal Results
13th Feb 20236:02 pmRNSHolding(s) in Company
10th Feb 20233:00 pmRNSHolding(s) in Company
8th Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20232:12 pmRNSHolding(s) in Company
2nd Feb 20234:27 pmRNSHolding(s) in Company
30th Jan 20232:48 pmRNSHolding(s) in Company
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
25th Jan 20234:05 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
17th Jan 20234:40 pmRNSHolding(s) in Company
3rd Jan 20239:05 amRNSBlock listing Interim Review
3rd Jan 20239:00 amRNSTotal Voting Rights
21st Dec 20224:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.